Labeling Labels and a fine marker for tracking peptide name, concentration, reconstitution date, and 28-day discard date
It inhibits p-AKT, cyclin D1, CDK4, Bid, and Bcl-xL while upregulating p53/p21/Bax to induce S-phase arrest and apoptosis (Huang et al., 2013)
Topical doesn't get there
These include conventional PKC isoforms (PKC, PKCI, PKCII, and PKC), novel PKC isoforms (PKC, PKC, PKC, and PKC), and atypical PKC isoforms (PKC and PKC/) [37]
While not a cure for medical conditions, GHK-Cu is being studied for its potential in: Skin aging and photodamage Wound and scar healing Hair loss (alopecia, thinning) Inflammatory skin disorders Post-procedure recovery It may be applied topically, through microneedling, or as part of a peptide therapy program tailored to individual goals
Similar to the 2-BP treatment, the eGFP-GLUT1 C207S mutant displayed cytoplasmic distribution in U87 and T98G cells (Supplementary Fig